Large biomolecules such as immunoglobulin M, immunoglobulin A, virus-like particles (VLPs), plasma proteins, and polyethylene glycol (PEG)-conjugated proteins are difficult to purify because of their ...
Monoclonal antibodies (mAbs) are now one of the major class of therapeutics, approved for a wide range of clinical uses. As biopharmaceuticals, mAbs must meet high purity and safety standards ā but as ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The new purification resin is expected to improve monoclonal antibody purification capacity by up to 40% due to its high binding capacity. On Sep. 22, 2017, GE Healthcare announced a new Protein A ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Labile, poorly expressed, or poorly soluble proteins paose many difficulties in isolation and purification. These difficulties can be overcome, however, by various means. One approach is to modify ...
Amicogen (CEO Park Cheol), a leading company in the bio-materials and pharmaceutical fields, announced that it has successfully developed a next-generation ligand for antibody purification and ...
Monoclonal antibody drugs treat a wide variety of clinical indications - for cancer treatments, mAbs enlist natural immune system functions to fight the disease RADNOR, Pa., March 18, 2020 /PRNewswire ...
Resin purification. A French partnership has received a patent for a process that removes impurities from postconsumer polyolefins, with the goal of making them suitable for use in automotive parts ...
Effective and efficient protein purification processes are essential in drug discovery and development. Affinity fusion tags are commonly used in protein purification due to their ability to enable ...
WALTHAM, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results